A Phase III trial evaluating nex-z in transthyretin amyloidosis with cardiomyopathy is underway, with plans for another ...

NEW YORK – Bluebird Bio on Friday said it will be purchased by funds managed by investment firms Carlyle and SK Capital Partners, after which it will become a privately held company. Under the terms ...

In a previous trial, patients with RSK2-high cancers had a significantly greater benefit from treatment with PMD-026 than those with RSK2-low cancers.

Blincyto plus chemo was approved for adult patients with Ph-negative, CD19-positive, and MRD-negative B-cell precursor acute lymphoblastic leukemia.

The firm plans to build on its organ and tissue modeling technology to develop more sophisticated tests, including full-body digital twins.

Researchers explored how Pluvicto is used in the community and academic settings and when given by oncologists or urologists.

The registrational trial will include 212 patients who are newly diagnosed with advanced head and neck cancer.

Boehringer Ingelheim, IP Group, UK Respiratory Gene Therapy Consortium, and OXB launched the first-in-human clinical trial, known as LENTICLAIR 1.

Researchers will launch a randomized clinical trial to assess whether PGx-guided care helps keep patients out of the ER and ...